Inspire Youths, Llc Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 206 Laken Dr, West Palm Bch, FL 33409 Phone: 561-801-4946 |
New Beginnings Behavioral Solutions Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1645 Palm Beach Lakes Blvd Ste 1200, West Palm Bch, FL 33401 Phone: 305-301-7667 |
Margo Behavior Inc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1645 Palm Beach Lakes Blvd Ste 1200, West Palm Bch, FL 33401 Phone: 786-739-0068 Fax: 561-464-5953 |
News Archive
Five years ago, a highly publicized meta-analysis of more than 200 studies concluded that organic food was no more nutritious than conventionally grown food.
In the largest study of its kind, pediatric researchers at The Children's Hospital of Philadelphia have received a federal contract for a project to determine the most beneficial method of using antibiotics to treat urinary tract infections (UTIs) in children.
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.
Uninsured residents of the Hartford area in need of medical attention should call 877-233-5159 toll-free as soon as possible to schedule appointments for a free health clinic at the Connecticut Convention Center on Feb. 3.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
› Verified 9 days ago